CRBU - Company ID 0001619856
The table below shows Caribou Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.19M | $12.06M | $11.14M | $25.20M | $29.42M | $31.97M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $203.00K | $227.00K | $242.00K | $71.00K | $88.00K | $184.00K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $116.59M |
| $122.38M |
| $155.51M |
| $192.51M |
| $217.32M |
| $237.43M |
| Property, plant & equipment | $5.50M | $6.12M | $7.60M | $8.18M | $18.52M | $19.57M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $142.77M | $149.00M | $194.98M | $220.90M | $273.66M | $344.33M |
| Accounts payable | $3.08M | $3.50M | $3.80M | $3.24M | $3.87M | $2.70M |
| Total current liabilities | $17.97M | $19.67M | $28.06M | $28.89M | $28.49M | $32.16M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $44.67M | $46.98M | $53.14M | $54.77M | $56.43M | $63.13M |
| Retained earnings | -$645.88M | -$621.60M | -$570.03M | -$542.48M | -$488.38M | -$412.90M |
| Total equity | $98.10M | $102.02M | $141.84M | $166.13M | $217.22M | $281.20M |